- Tytuł:
-
Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible
tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial. - Autorzy:
- Źródło:
- BMC infectious diseases [BMC Infect Dis] 2023 May 08; Vol. 23 (1), pp. 300. Date of Electronic Publication: 2023 May 08.
- Typ publikacji:
- Clinical Trial Protocol; Journal Article
- MeSH Terms:
-
Rifampin*/adverse effects
Tuberculosis */drug therapy
Humans ; Isoniazid/adverse effects ; Pyrazinamide ; Moxifloxacin/therapeutic use ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic
Czasopismo naukowe